United States - English - NLM (National Library of Medicine)

bayer healthcare llc animal health division - pradofloxacin (unii: 6o0t5e048i) (pradofloxacin - unii:6o0t5e048i) - pradofloxacin 25 mg in 1 ml - veraflox is indicated for the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of pasteurella multocida, streptococcus canis, staphylococcus aureus, staphylococcus felis, and staphylococcus pseudintermedius. do not use in dogs. pradofloxacin has been shown to cause bone marrow suppression in dogs. dogs may be particularly sensitive to this effect, potentially resulting in severe thrombocytopenia and neutropenia. quinolone-class drugs have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. pradofloxacin is contraindicated in cats with a known hypersensitivity to quinolones.

European Union - English - EMA (European Medicines Agency)

bayer animal health gmbh  - pradofloxacin - antibacterials for systemic use, fluoroquinolones - dogs; cats - dogstreatment of:wound infections caused by susceptible strains of the staphylococcus intermedius group (including s. pseudintermedius);superficial and deep pyoderma caused by susceptible strains of the staphylococcus intermedius group (including s. pseudintermedius);acute urinary-tract infections caused by susceptible strains of escherichia coli and the staphylococcus intermedius group (including s. pseudintermedius);as adjunctive treatment to mechanical or surgical periodontal therapy in the treatment of severe infections of the gingiva and periodontal tissues caused by susceptible strains of anaerobic organisms, for example porphyromonas spp. and prevotella spp.catstreatment of acute infections of the upper respiratory tract caused by susceptible strains of pasteurella multocida, escherichia coli and the staphylococcus intermedius group (including s. pseudintermedius).

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - pradofloxacin - unknown - pradofloxacin antibiotic active 0.0 - active constituent

United States - English - NLM (National Library of Medicine)

elanco us inc. - pradofloxacin (unii: 6o0t5e048i) (pradofloxacin - unii:6o0t5e048i) - do not use in dogs. pradofloxacin has been shown to cause bone marrow suppression in dogs. dogs may be particularly sensitive to this effect, potentially resulting in severe thrombocytopenia and neutropenia. quinolone-class drugs have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. pradofloxacin is contraindicated in cats with a known hypersensitivity to quinolones.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - pradofloxacin - oral solution/suspension - pradofloxacin antibiotic active 25.0 mg/ml - antibiotic & related

New Zealand - English - Ministry for Primary Industries

elanco new zealand - pradofloxacin - pradofloxacin 150 g/kg - antibiotic

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - pradofloxacin - oral tablet - pradofloxacin antibiotic active 15.0 mg/tb - antibiotic & related

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - pradofloxacin - oral tablet - pradofloxacin antibiotic active 120.0 mg/tb - antibiotic & related

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - pradofloxacin - oral tablet - pradofloxacin antibiotic active 60.0 mg/tb - antibiotic & related

New Zealand - English - Ministry for Primary Industries

elanco new zealand - pradofloxacin - pradofloxacin 25 g/litre - antibiotic